| Autor: |
Zubiaur, Pablo, Saiz-Rodríguez, Miriam, Koller, Dora, Ovejero-Benito, María Carmen, Wojnicz, Aneta, Abad-Santos, Francisco |
| Zdroj: |
Pharmacogenomics; November 2018, Vol. 19 Issue: 16 p1285-1297, 13p |
| Abstrakt: |
Several polymorphisms have been identified in ABCB1, the gene encoding for the P-glycoprotein. This transporter alters the pharmacokinetics or effectiveness of drugs by excreting them from cells where it is expressed (e.g., blood–brain barrier, intestine or tumors). No consensus has been reached regarding the functional consequences of these polymorphisms in the transporter's function. The aim of this review was to describe a methodology that allows the assessment of P-gp function when harboring polymorphisms. We describe how to obtain cell lines with high expression levels of the transporter with polymorphisms and several tactics to measure its expression and activity. This methodology may help elucidate the contribution of polymorphisms in ABCB1to drug pharmacokinetics, effectiveness and safety or to cancer chemotherapy failure. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
